Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, People's Republic of China.
J Craniofac Surg. 2024;35(1):e52-e56. doi: 10.1097/SCS.0000000000009801. Epub 2023 Nov 8.
Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is a relatively uncommon autosomal-dominant genetic disorder, primarily attributed to mutations in the forkhead box L2 (FOXL2) gene. Albeit the involvement of protein-coding regions of FOXL2 has been observed in the majority of BPES cases, whether deficiencies in regulatory elements lead to the pathogenesis remains poorly understood. Herein, an autosomal-dominant BPES type II family was included. Peripheral venous blood has been collected, and genomic DNA has been extracted from leukocytes. A whole exome sequencing analysis has been performed and analyzed (Deposited in NODE database: OER422653). The promoter region of FOXL2 was amplified using polymerase chain reaction (PCR). The luciferase reporter assay was performed to identify the activity of this region. In this study, we present a Chinese family diagnosed with type II BPES, characterized by the presence of small palpebral fissures, ptosis, telecanthus, and epicanthus inversus. Notably, all male individuals within the family display polydactyly. A 225-bp deletion in the 556-bp 5'-upstream to transcription start site of FOXL2 , decorated by multiple histone modifications, was identified in affected members of the family. This deletion significantly decreased FOXL2 promoter activity, as measured by the luciferase assay. Conclusively, a novel 255-bp-deletion of the FOXL2 promoter was identified in Chinese families with BPES. Our results expand the spectrum of known FOXL2 mutations and provide additional insight into the genotype-phenotype relationships of the BPES pathogenesis. In addition, this study indicates the important role of genetic screening of cis-regulatory elements in testing heritable diseases.
眼睑下垂-上睑下垂-内眦赘皮综合征(BPES)是一种相对罕见的常染色体显性遗传疾病,主要归因于叉头框 L2(FOXL2)基因突变。尽管 FOXL2 的蛋白编码区域的突变已在大多数 BPES 病例中被观察到,但调节元件的缺陷是否导致发病机制仍知之甚少。在此,我们纳入了一个常染色体显性遗传的 II 型 BPES 家族。采集外周静脉血,从白细胞中提取基因组 DNA。进行了全外显子组测序分析并进行了分析(存入 NODE 数据库:OER422653)。使用聚合酶链反应(PCR)扩增 FOXL2 的启动子区域。进行了荧光素酶报告基因检测以确定该区域的活性。在这项研究中,我们提出了一个中国家族,该家族被诊断为 II 型 BPES,其特征是小睑裂、上睑下垂、内眦赘皮和内眦赘皮倒转。值得注意的是,家族中的所有男性个体都有多指畸形。在受影响的家族成员中,鉴定出 FOXL2 的 5'-转录起始位点上游的 556bp 启动子区域中存在 225bp 的缺失,该缺失区域被多种组蛋白修饰所修饰。通过荧光素酶检测,该缺失显著降低了 FOXL2 启动子的活性。总而言之,在中国的 BPES 家族中发现了一种新的 FOXL2 启动子 255bp 缺失。我们的结果扩展了已知 FOXL2 突变的谱,并为 BPES 发病机制的基因型-表型关系提供了更多的见解。此外,本研究表明,对顺式调节元件进行遗传筛选在检测遗传性疾病方面具有重要作用。